These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21888450

  • 1. Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2012 Feb 01; 13(1):37-47. PubMed ID: 21888450
    [Abstract] [Full Text] [Related]

  • 2. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2010 Dec 01; 11(6):423-32. PubMed ID: 20429617
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    J Eur Acad Dermatol Venereol; 2010 Jul 01; 24(7):789-96. PubMed ID: 20002653
    [Abstract] [Full Text] [Related]

  • 4. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S, Oliveira H, Belo L, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2013 Feb 01; 14(1):49-53. PubMed ID: 23329079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R, Hristakieva E, Aydin U, Gancheva D, Gancheva T, Zheleva A, Gadjeva V, Fluhr JW.
    J Dermatol Sci; 2018 Jul 01; 91(1):28-34. PubMed ID: 29610017
    [Abstract] [Full Text] [Related]

  • 9. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
    Silver S, Tuppal R, Gupta AK, Clonier F, Olesen M, Leeder R, Taraska V.
    J Drugs Dermatol; 2013 Aug 01; 12(8):882-7. PubMed ID: 23986161
    [Abstract] [Full Text] [Related]

  • 10. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
    Bagel J, Levi E, Tyring S, Knuckles ML.
    J Drugs Dermatol; 2014 Nov 01; 13(11):1374-9. PubMed ID: 25607705
    [Abstract] [Full Text] [Related]

  • 11. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A, Gold LS, Bukhalo M, Grekin S, Kempers S, Boyce BM, Ganslandt C, Villumsen J, Lebwohl M.
    J Drugs Dermatol; 2013 Jan 01; 12(1):92-8. PubMed ID: 23377334
    [Abstract] [Full Text] [Related]

  • 12. Management of guttate and generalized psoriasis vulgaris: prospective randomized study.
    Caca-Biljanovska NG, V'lckova-Laskoska MT.
    Croat Med J; 2002 Dec 01; 43(6):707-12. PubMed ID: 12476481
    [Abstract] [Full Text] [Related]

  • 13. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
    Torras H, Aliaga A, López-Estebaranz JL, Hernández I, Gardeazabal J, Quintanilla E, Mascaró JM.
    J Dermatolog Treat; 2004 Apr 01; 15(2):98-103. PubMed ID: 15204160
    [Abstract] [Full Text] [Related]

  • 14. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF, Iqbal SJ, Hutchinson PE.
    Clin Exp Dermatol; 1997 Nov 01; 22(6):259-61. PubMed ID: 9604449
    [Abstract] [Full Text] [Related]

  • 15. Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis.
    Roussaki-Schulze AV, Kouskoukis C, Klimi E, Zafiriou E, Galanos A, Rallis E.
    Drugs Exp Clin Res; 2005 Nov 01; 31(5-6):169-74. PubMed ID: 16425972
    [Abstract] [Full Text] [Related]

  • 16. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL.
    Am J Clin Dermatol; 2011 Dec 01; 12(6):421-4. PubMed ID: 21967117
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of non-laser, targeted UVB phototherapy alone and in combination with psoralen gel or calcipotriol ointment in the treatment of localized, chronic, plaque-type psoriasis.
    Ozkan I, Köse O, Ozmen I, Arca E.
    Int J Dermatol; 2012 May 01; 51(5):609-13. PubMed ID: 22515588
    [Abstract] [Full Text] [Related]

  • 18. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A, Dicle O, Yilmaz F, Coskun M, Yilmaz E.
    Photodermatol Photoimmunol Photomed; 2008 Jun 01; 24(3):123-7. PubMed ID: 18477130
    [Abstract] [Full Text] [Related]

  • 19. A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study.
    Thaçi D, Ortonne JP, Chimenti S, Ghislain PD, Arenberger P, Kragballe K, Saurat JH, Khemis A, Sprøgel P, Esslinger HU, Unnebrink K, Kupper H.
    Br J Dermatol; 2010 Aug 01; 163(2):402-11. PubMed ID: 20377585
    [Abstract] [Full Text] [Related]

  • 20. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH.
    J Drugs Dermatol; 2011 Aug 01; 10(8):878-82. PubMed ID: 21818509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.